More: Manufacturing News of Note—Samsung Bioepis, Biogen add to biosimilars; Boehringer Ingelheim to add 105 jobs in Puerto Rico Source: fierce
read moreCompetition in the multiple sclerosis field has stepped up significantly, thanks to several recent drug launches. But in that fray, Merck KGaA’s Mavenclad can be counted as one successful rollout—at least so far—as its third-quarter sales offset losses for the
read moreThe organisation updates its MS Guideline to state that Sativex should be offered to treat spasticity in people with the disorder. More: NICE ‘OK’ for Sativex in MS Source: News
read moreThe study is the sixth Phase III trial of the drug’s programme. More: Lilly, Boehringer initiate Jardiance heart failure trial Source: News
read moreOnly one drug has been approved for the indication in the lat 60 years, GlaxoSmithKline’s Benlysta (belimumab), which was also the first-ever biologic treatment for the disease. More: AZ releases positive anifrolumab data Source: News
read moreMore than half of the public are not aware the condition may be preventable, and just under half are unaware of the steps that can be taken to prevent or delay the development of the condition. More: Survey shows “lack
read more© 1994 - 2026 B.M. Pharmaceuticals